C15H20NNaO4
301.31 g/mol
Pharmaceutical IntermediateWarning
Salcaprozate sodium
CAS203787-91-1EC807-387-2
Category
Pharmaceutical Intermediate
Compound Class
Amide
Primary Use
Pharmaceutical Intermediate
Salcaprozate sodium is the sodium salt form of salcaprozate, used as an oral absorption promoter. It is a compound employed in pharmaceutical manufacturing to enhance the oral bioavailability of certain macromolecules such as insulin and heparin.
oral absorption promoterdelivery agent for macromolecules with poor bioavailability
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 203787-91-1
Related Compounds
ReferenceSame Category
2-morpholinoethylamine
CAS2038-03-1
pharmaceutical intermediate
ReferenceSame Category
N-BOC-4,4-difluoro-L-proline
CAS203866-15-3
pharmaceutical intermediate
ReferenceSame Category
Tert-Butyl (R)-3-(methylamino)piperidine-1-carboxylate
CAS203941-94-0
pharmaceutical intermediate
ReferenceSame Category
1-(2-Methylphenyl)propan-1-one
CAS2040-14-4
pharmaceutical intermediate
Referencestereoisomer of
Salcaprozic acid
CAS183990-46-7
pharmaceutical raw material
Safety Reference
Warning
H302Harmful if swallowed
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name
sodium 8-[(2-hydroxybenzoyl)amino]octanoate
InChIKey
UOENJXXSKABLJL-UHFFFAOYSA-M
SMILES
C1=CC=C(C(=C1)C(=O)NCCCCCCCC(=O)[O-])O.[Na+]
Synonyms (17)
- E414
- P414
- SNAC
- Salcaprozate sodium (USAN)
- SNAC sodium
- Salcaprozate sodium
- Salcaprozic acid, sodium salt
- Sodium salcaprozate